United Kingdom Respiratory Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

United Kingdom Respiratory Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The United Kingdom respiratory devices market is expected to register a CAGR of 10% over the forecast period (2022-2027).

The United Kingdom respiratory devices market is expected to show good growth due to the increasing prevalence of respiratory disorders, such as COPD, TB, asthma, and sleep apnea, along with technological advancements and increasing applications in the home care settings.

An article titled “Care of chronic respiratory disease in the United Kingdom in the time of the COVID-19 pandemic” published by the World Health Organization Regional Office on Europe in January 2021 illustrated that the COVID-19 pandemic had caused an uproar in the use of ventilators among other respiratory devices in the nation. In January 2021, the Royal Brompton Hospital in London supported over 11,000 patients in continuous positive airway pressure (CPAP) machines and over 2000 patients in ventilators. The large number of devices required during the COVID-19 pandemic also added to the market growth over the forecast period.

There is a high incidence of respiratory diseases and these diseases have affected one in five people. These respiratory diseases are the third-largest cause of death in England (after cancer and cardiovascular disease). As per the May 2022 update on respiratory diseases published by Public Health England, respiratory diseases accounted for 1.1 million hospital admissions in the year 2019-2020. The article also stated that the number of respiratory diseases increased hospital admissions during the winter, placing a burden on the National Health Services. The large population affected by respiratory problems who require respiratory devices for their betterment is likely to add to the growth of the studied market.

Also, as per the Occupational Lung Disease statistics in Great Britain, 2021, an estimate of 17,000 new cases of breathing and lung problems were recorded each year in the country, with the condition being caused as a result of either work or worsened by their work. Such high incidences of respiratory problems in the nation are expected to propel the growth of the United Kingdom respiratory devices market over the forecast period.

The incidence and mortality rates from respiratory diseases are higher, with the gap widening and leading to worse health outcomes. The most deprived communities have a higher incidence of smoking rates, exposure to higher levels of air pollution, poor housing conditions, and exposure to occupational hazards that are increasing respiratory disorders among the population. Furthermore, the medical devices industry of the United Kingdom is primarily comprised of small- and medium-sized companies that are increasing the overall respiratory devices market.

However, the high cost of the respiratory devices are likely to hinder the growth of the market over the forecast period.

Key Market TrendsSpirometers are Expected to be the Dominant Sub-segment in Diagnostic and Monitoring Devices Over the Forecast Period

Spirometers help in diagnosing respiratory diseases, such as asthma, emphysema, bronchitis, and chronic obstructive pulmonary diseases. Furthermore, they can also be used to assess shortness of breath, lung function before surgery, and the effect of medication.

According to the National Health Services Quality and Outcomes Framework (QOF) 2020-2021 data on prevalence of diseases in the United Kingdom, around 60,716,244 people in the united Kingdom were affected by chronic obstructive pulmonary disease during 2020-2021 and the disease had a prevalence rate of 1.93%. The large number of people being affected by chronic obstructive pulmonary disease cases, thereby increasing the demand for respiratory devices, are likely to significantly boost the growth of the market over the forecast period in the United Kingdom.

The spirometers segment has been fueled by the recent technological advancements in the field of spirometry that include the development of small portable spirometers and the increasing accuracy, acceptability, and reproducibility of assessments with immediate feedback to the technician. Thus, the applications of spirometers make it easier for the patient to use this diagnostic device and is also increasingly adopted in hospitals and home care, globally, which is expected to drive the market growth in the forecast period.

Several key market players have also announced several innovative spirometers for patients in the United Kingdom, which are boosting the market growth. For instance, in March 2021, Vyaire Medical launched its innovative remote Aiocare mobile spirometer in the United Kingdom. The device helps to promptly diagnose pulmonary diseases including asthma and COPD as accurately as hospital-grade spirometers. Such product launches in the nation are expected to propel the growth of the United Kingdom respiratory devices market over the forecast period.

Competitive Landscape

Some of the established companies for respiratory devices in United Kingdom include Medtronic, Philips, GSK, GE Healthcare etc.. These companies present in the market are found focusing on product innovations, expansions, finding new markets, or innovating their core competency to expand their individual market share.

Additional Benefits:
  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support
Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.


1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Prevalence of Respiratory Disorders, such as COPD, Asthma, and Sleep Apnea
4.2.2 Technological Advancements and Increasing Applications in Home Care Settings
4.3 Market Restraints
4.3.1 High Cost of Devices
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION (Market Size by Value - in USD Millions)
5.1 By Type
5.1.1 By Diagnostic and Monitoring Devices
5.1.1.1 Spirometers
5.1.1.2 Sleep Test Devices
5.1.1.3 Peak Flow Meters
5.1.1.4 Pulse Oximeters
5.1.1.5 Capnographs
5.1.1.6 Other Diagnostic and Monitoring Devices
5.1.2 By Therapeutic Devices
5.1.2.1 CPAP Devices
5.1.2.2 BiPAP Devices
5.1.2.3 Humidifiers
5.1.2.4 Nebulizers
5.1.2.5 Oxygen Concentrators
5.1.2.6 Ventilators
5.1.2.7 Inhalers
5.1.2.8 Other Therapeutic Devices
5.1.3 By Disposables
5.1.3.1 Masks
5.1.3.2 Breathing Circuits
5.1.3.3 Other Disposables
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 DeVilbiss Healthcare LLC
6.1.2 Dragerwerk AG
6.1.3 Fisher & Paykel Healthcare Ltd
6.1.4 GE Healthcare
6.1.5 GlaxoSmithKline PLC
6.1.6 Koninklijke Philips NV
6.1.7 Medtronic PLC
6.1.8 ResMed Inc.
6.1.9 Invacare Corporation
7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings